World's Best Scientists 2026 revealed!
Award Badge
Immunology
Greece
2026

D-Index & Metrics

Immunology

D-Index
101
Citations
48851
World Ranking
689
National Ranking
3

Medicine

D-Index
102
Citations
49666
World Ranking
7544
National Ranking
19

George Kollias publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where George Kollias sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 376 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

George Kollias D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where George Kollias sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Greece Leader Award
  • 2025 - Research.com Immunology in Greece Leader Award
  • 2023 - Research.com Immunology in Greece Leader Award
  • 2022 - Research.com Immunology in Greece Leader Award
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

George Kollias is affiliated with the National and Kapodistrian University of Athens in Greece. Their research spans multiple fields within the biomedical sciences, with primary focus areas including Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. These disciplines are supported by a substantial body of publications and collaborations.

Their work engages with various subfields such as Immunology, Molecular Biology, Oncology, Rheumatology, and Genetics. Key research topics addressed in their publications include Cytokine Signaling Pathways and Interactions, Immune cells in cancer, Rheumatoid Arthritis Research and Therapies, IL-33, ST2, and ILC Pathways, Cancer Cells and Metastasis, Spondyloarthritis Studies and Treatments, and Single-cell and spatial transcriptomics.

Recent scholarly publications by George Kollias cover diverse aspects of immunology, inflammation, cancer, and arthritis. Selected papers include:

  • "Fibroblasts as immune regulators in infection, inflammation and cancer" (2021) published in Nature Reviews. Immunology
  • "Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche" (2020) published in Nature
  • "The mesenchymal context in inflammation, immunity and cancer" (2020) published in Nature Immunology
  • "'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models" (2021) published in Annals of the Rheumatic Diseases
  • "The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era" (2022) published in Rheumatology International

Frequent collaborators in their research include Maria C. Denis, Niki Karagianni, Marietta Armaka, Christos Tzaferis, and Lydia Ntari.

Their work has been disseminated through several leading publication venues, with notable frequency in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • Nature Immunology
  • Physica Medica
  • Annals of the Rheumatic Diseases

George Kollias has been recognized by the scientific community with membership in the European Molecular Biology Organization (EMBO), indicating their active role within molecular biology networks and governance.

Best Publications

  • The Transcriptional Landscape of the Mammalian Genome

    P. Carninci;T. Kasukawa;S. Katayama;J. Gough

  • Position-independent, high-level expression of the human β-globin gene in transgenic mice

    Frank Grosveld;Greet Blom van Assendelft;David R. Greaves;George Kollias

  • Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

    J. Keffer;L. Probert;H. Cazlaris;S. Georgopoulos

  • Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

    Séverine Boillée;Koji Yamanaka;Christian S. Lobsiger;Neal G. Copeland

  • THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR

    Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden

  • Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

    Dimitris Kontoyiannis;Manolis Pasparakis;Theresa Torres Pizarro;Fabio Cominelli

  • CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.

    Paola Bezzi;Maria Domercq;Liliana Brambilla;Rossella Galli

  • Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

    M Pasparakis;L Alexopoulou;V Episkopou;G Kollias

  • Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

    Robert J. Moore;David M. Owens;Gordon Stamp;Caroline Arnott

  • TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

    Calin D. Dumitru;Jeffrey D. Ceci;Christos Tsatsanis;Dimitris Kontoyiannis

  • Interleukin 6 is required for the development of collagen-induced arthritis.

    Tonino Alonzi;Elena Fattori;Domenico Lazzaro;Patrizia Costa

  • Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

    Jean-Christophe Plumier;B. Ross;R. W. Currie;C. E. Angelidis

  • Osteoclasts are essential for TNF-α–mediated joint destruction

    Kurt Redlich;Silvia Hayer;Romeo Ricci;Jean-Pierre David

  • Fibroblasts as immune regulators in infection, inflammation and cancer

    Sarah Davidson;Mark Coles;Tom Thomas;George Kollias

  • MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.

    Armin Neininger;Dimitris Kontoyiannis;Alexey Kotlyarov;Reinhard Winzen

  • PREDOMINANT PATHOGENIC ROLE OF TUMOR NECROSIS FACTOR IN EXPERIMENTAL COLITIS IN MICE

    Markus F. Neurath;Ivan Fuss;Manolis Pasparakis;Lena Alexopoulou

  • Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level Implications for Pathogenesis and Therapy of Autoimmune Demyelination

    George Kassiotis;George Kollias

  • Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

    Lesley Probert;Katerina Akassoglou;Manolis Pasparakis;George Kontogeorgos

  • Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.

    Ralph Gareus;Elena Kotsaki;Sofia Xanthoulea;Ingeborg van der Made

  • Mast Cells Control Neutrophil Recruitment during T Cell–Mediated Delayed-Type Hypersensitivity Reactions through Tumor Necrosis Factor and Macrophage Inflammatory Protein 2

    Tilo Biedermann;Manfred Kneilling;Reinhard Mailhammer;Konrad Maier

  • The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans

    Kellie A. Charles;Hagen Kulbe;Robin Soper;Monica Escorcio-Correia

Frequent Co-Authors

Manolis Pasparakis
Manolis Pasparakis University of Cologne
Lesley Probert
Lesley Probert Institut Pasteur
Georg Schett
Georg Schett University of Erlangen-Nuremberg
George Kassiotis
George Kassiotis The Francis Crick Institute
Lena Alexopoulou
Lena Alexopoulou Centre d’Immunologie de Marseille-Luminy
Jochen Zwerina
Jochen Zwerina University of Erlangen-Nuremberg
Katerina Akassoglou
Katerina Akassoglou University of California, San Francisco
Frank Grosveld
Frank Grosveld Erasmus University Rotterdam
Hans Lassmann
Hans Lassmann Medical University of Vienna
Dirk Elewaut
Dirk Elewaut Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degrees can open doors to diverse career pathways. Many students pivot into specialized nursing roles, such as pursuing an acute care certification for FNP, enabling advanced practice in critical care settings. This certification caters to Family Nurse Practitioners looking to shift focus toward acute patient needs.

Accelerated nursing programs provide a fast track for professionals seeking to elevate their qualifications. The accelerated NP programs are designed for those wanting to become Nurse Practitioners quickly, blending rigorous coursework with flexible online formats.

Individuals without a nursing background can transition into this field through online ABSN programs for non nurses. These programs provide comprehensive training to build foundational skills, preparing students efficiently for a nursing career.

For students concerned about admission, exploring ABSN programs with high acceptance rates offers accessible options without compromising quality education. These pathways can serve as critical stepping stones toward advanced immunology and healthcare roles.

Best Scientists Citing George Kollias

Trending Scientists

Recently Published Articles